Based in Stockholm, Swedem since 2003, Vacara AB is a translational biotech company developing humanized disease models, preclinical immunology services, and immune-focused platforms for therapeutic and diagnostic development. The company works across autoimmune, inflammatory, and immune-oncology diseases, including humanized models, biomarker platforms, vaccine programs, and preclinical studies, with a focus on improving the predictability of drug development through more human-relevant biology.